FDA OKs Vyzulta for Glaucoma, Ocular Hypertension FDA OKs Vyzulta for Glaucoma, Ocular Hypertension

Latanoprostene bunod is a novel nitric-oxide-donating prostaglandin analogue that ' s been shown to provide consistent and sustained reduction of intraocular pressure.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news